In an Asian esophageal squamous cell carcinoma cohort, researchers found that BRIP1 mutant was an adverse factor for OS and the cohort harboured TP53 signalling pathway alterations altered NOTCH, RTK-RAS, and cell cycle pathway, which might explain the phenomenon [30]. The gene discussed is TP53; the disease is esophageal squamous cell carcinoma.